Aprea Therapeutics, Inc. Liability for Uncertainty in Income Taxes, Noncurrent
Aprea Therapeutics, Inc. (APRE) had Liability for Uncertainty in Income Taxes, Noncurrent of $100.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LiabilityForUncertainTaxPositionsNoncurrent · last filed 2026-08-12
- 2026-06-30: Liability for Uncertainty in Income Taxes, Noncurrent $100.00K.
- 2026-03-31: Liability for Uncertainty in Income Taxes, Noncurrent $100.00K.
- 2025-12-31: Liability for Uncertainty in Income Taxes, Noncurrent $100.00K.
- 2025-09-30: Liability for Uncertainty in Income Taxes, Noncurrent $100.00K.
| Period end | Liability for Uncertainty in Income Taxes, Noncurrent |
|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $100.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $100.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $100.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $100.00K 10-K · filed 2025-03-25 |
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $100.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $100.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $100.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $100.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $100.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $100.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $800.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $800.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $800.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $800.00K 10-K · filed 2023-03-30 |
| 2019-12-31 | $0.00 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |